series-c-plus
Stage
6
Investors
About
PhiTech develops an AI-driven multi-omics platform that integrates genomic (WES/WGS) and transcriptomic (RNA-Seq) data to improve diagnostic accuracy and speed for rare diseases and hereditary cancers.
Explore PhiTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.